Abstract
A novel polycationic analogue of gratisin, cyclo(-Val-Orn-Leu-D-Phe-Pro-D-Lys-)2, was designed and synthesized, which exhibited strong activity against all Gram-positive and Gram-negative bacteria tested. Its activity against Pseudomonas aeruginosa IFO 3080 was two times higher than gramicidin S.
MeSH terms
-
Anti-Bacterial Agents / chemical synthesis
-
Anti-Bacterial Agents / chemistry*
-
Anti-Bacterial Agents / pharmacology*
-
Antimicrobial Cationic Peptides / chemical synthesis
-
Antimicrobial Cationic Peptides / chemistry*
-
Antimicrobial Cationic Peptides / pharmacology*
-
Circular Dichroism
-
Drug Design
-
Gram-Negative Bacteria / drug effects*
-
Gram-Positive Bacteria / drug effects*
-
Microbial Sensitivity Tests
-
Peptides / chemical synthesis
-
Peptides / chemistry*
-
Peptides / pharmacology*
-
Peptides, Cyclic / chemical synthesis
-
Peptides, Cyclic / chemistry*
-
Peptides, Cyclic / pharmacology*
-
Pseudomonas aeruginosa / drug effects
Substances
-
Anti-Bacterial Agents
-
Antimicrobial Cationic Peptides
-
Peptides
-
Peptides, Cyclic
-
cyclo(valyl-ornithyl-leucyl-phenylalanyl-prolyl-lysyl)2
-
gratisin